Toni K. Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, presents findings from the phase 3 LITESPARK-022 study at the 2026 American Society of ...
Safety and efficacy evaluation of nadofaragene firadenovec instilled into the renal pelvis in subjects with low-grade upper tract urothelial carcinoma (LG-UTUC): A single-arm, open-label phase 1/2 ...
EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology’s ...
FORT MYERS, Fla., Feb. 26, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO (R) 2026 ...
The presentations at ASCO GU signal a move toward more personalized, potent, and sequence-specific treatment strategies for genitourinary malignancies.
Discover genitourinary syndrome of menopause (GSM), its causes, symptoms, and treatments, including hormonal and nonhormonal ...
Oprah Daily on MSN
There aren’t many great sensual wellness tools for menopausal women—so this doctor created one herself
Dr. Kelly Casperson shares the inspiration behind The Explorer, and why sexual pleasure changes as you age.
remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...
Sacituzumab govitecan (SG) is a TROP2-directed antibody-drug conjugate with a payload of SN-38, a topoisomerase inhibitor. SG monotherapy has demonstrated activity in multiple solid tumors, including ...
Please provide your email address to receive an email when new articles are posted on . Genitourinary syndrome of menopause is common but often underrecognized in dermatology. Low-dose vaginal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results